Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Acupuncture and Moxibustion Treatment in Patients With Active Crohn's Disease and Its Regulation Mechanism to the Immune Homeostasis Mediated by Th17/Treg Cells

NCT01697761 is registered in ClinicalTrials.gov with Shanghai Institute of Acupuncture, Moxibustion and Meridian as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01697761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Acupuncture and Moxibustion Treatment in Patients With Active Crohn's Disease and Its Regulation Mechanism to the Immune Homeostasis Mediated by Th17/Treg Cells
Lead sponsor
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2012
Completion date
November 30, 2014
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cam, crohn's disease